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Abstract
Background: This study examined whether activation of innate immunity and alterations of carbohydrate and lipid
metabolism precede development of subclinical mastitis (SCM).
Methods: Blood samples were collected from the coccygeal vein from 100 Holstein dairy cows at -8, -4, disease
diagnosis week, and +4 weeks postpartum. Six healthy cows (controls – CON) and six cows that showed clinical
signs of SCM were selected for serum analyses. All serum samples were analyzed for acute phase proteins (APP)
haptoglobin (Hp) and serum amyloid A (SAA); proinflammatory cytokines including interleukin 1 (IL-1), IL-6, and
tumor necrosis factor (TNF) and serum lactate, BHBA, and NEFA concentration. Data of DMI, milk production, and
milk composition were recorded and analyzed.
Results: The results showed that cows with SCM had greater concentrations of SAA, TNF (P < 0.01), and lactate before
expected day of parturition (P < 0.05) compared to CON cows. Cows with SCM showed greater concentrations of
lactate starting at -8 weeks (P < 0.05) and TNF starting at -4 weeks prior to the expected day of parturition (P < 0.01).
Interestingly, at -4 weeks, concentrations of IL-1 and Hp were lower in cows with SCM compared to healthy cows (P <
0.01) followed by an increase during the week of disease diagnosis (P < 0.05). Subclinical mastitis was associated with
lower DMI, at -4 weeks before calving, milk production (P < 0.05) and increased somatic cell counts (SCC) (P < 0.01).
Conclusions: Results of this study suggest that SCM is preceded by activated innate immunity and altered
carbohydrate metabolism in transition dairy cows. Moreover the results support the idea that Hp, lactate, and SAA, at
-8 weeks, and TNF and IL-1 at -4 weeks can be used as early indicators to screen cows during dry off for disease state.
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Background
Subclinical mastitis (SCM) is the main form of mastitis
in dairy cattle and its prevalence ranges between 20 and
50 % of the cows in a herd [1, 2]. During SCM there are
no visible alterations in the appearance of milk or udder;
however, milk production decreases, somatic cell count
increase (SCC), bacterial pathogens are present in the
milk, and the milk composition is altered [3]. In Canada
the regulatory limit of SCC is 400,000 cells/mL of raw
milk [4]; however, International Dairy Federation (1997)
has determined that SCC > 200.000 cells/mL of milk
suggests presence of mastitis. A somatic cell score limit
of less than 100,000 cells/mL is suggested to be a healthy
level of SCC [5]. Moreover, the SCC for the composite
milk of a cow should not exceed 100,000 cells/mL [6].
Subclinical mastitis can cause major economic losses
due to lowering of milk production and lowering of shelf
life of milk. The cost of 1 case of SCM has been esti-
mated in the range of $200/year [7].
The inflammatory and immune responses to mastitis in-
fection affect the animal welfare and wellbeing and are as-
sociated with an important decrease in milk production
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and lower reproductive performance [8, 9]. The negative
consequences of mastitis on the reproductive efficiency of
dairy cows are not limited to its clinical form but are also
observed when the disease is at its subclinical stage [10].
Early identification of udder health problems is essential
for dairy industry to ensure the animal well-being and also
the milk quality and productivity. Moreover, cows with
SCM should be considered as a risk for spreading mastitis
pathogens within and between herds and as such are of
important concern [11].
Several studies have reported alterations in blood and
milk metabolites, proinflammatory cytokines, and acute
phase proteins in cows with SCM. For example, in-
creases in the concentration of lactate in the milk of
cows during mastitis, suggest that lactate could be a
good indicator of udder health [12, 13]. In addition, the
expression of interleukin (IL)-6 has been reported to in-
crease in cows with SCM [14]. It is believed that IL-1
and IL-6 are the two main triggers for production of
acute phase proteins (APP) by liver hepatocytes [15, 16].
Several APP have been well investigated as biomarkers
of mastitis in cows [16–18]. For example, concentrations
of serum amyloid A (SAA) are strongly elevated during
mild, moderate, and clinical mastitis [19–21]. In other
studies it was reported that concentration of haptoglobin
(Hp) in the serum increases in cows affected by clinical
or subclinical mastitis [22–25]. These findings suggest
that both Hp and SAA might be potential screening
biomarkers for bovine mastitis.
An increasing body of evidence suggests that changes
in the metabolic and innate immune variables in the
systemic circulation might start in the early stages of dis-
ease. Therefore early diagnosis or detection of those
alterations before development of subclinical disease
could help in developing preventive strategies in the fu-
ture. Therefore the objectives of the present investiga-
tion were to search for early screening biomarkers of
disease state in the blood of transition dairy cows start-
ing at -8 and -4 weeks prior to the expected day of
parturition, during the week of disease diagnosis, and up
to +4 weeks postpartum. The postpartum purpose of the
monitoring is to evaluate how long the disease lasts after
initiation. A group of variables traditionally related to in-
nate immunity and carbohydrate and lipid metabolism
will be included in the testing evaluation.
Methods
Animals and diets
All experimental procedures were approved by the
University of Alberta Animal Policy and Welfare
Committee for Livestock and animals were cared for in
accordance with the guidelines of the Canadian Council
on Animal Care [26].
One hundred pregnant Holstein dairy cows at the
Dairy Research and Technology Centre, University of
Alberta (Edmonton, AB, Canada), were used in a longi-
tudinal study. Six pregnant Holstein dairy cows (average
parity: 3.1 ± 0.4) were diagnosed with subclinical mastitis
and six healthy control cows (CON) that were similar in
parity, (average parity: 3.2 ± 0.3), age, and body condition
score (BCS), were selected for this nested case-control
study.
The experimental period lasted for 13 weeks starting
from -8 weeks before parturition to +4 weeks postpar-
tum (i.e. -8 weeks to +4 weeks, 0 week means the week
of calving) for each cow. Cows were housed in individual
tie stalls, bedded with sawdust and with free access to
water throughout the experiment. Shortly before calving
cows were transferred to the maternity barn and
returned to their stalls on the following day of partur-
ition. Diets were offered as TMR for ad libitum intake
once daily at 08.00 h to allow approximately 5 % orts.
All TMR were formulated to meet or exceed the nutri-
ent requirements of dry and early 680 kg lactating cows
as per National Research Council guidelines. Individual
dry matter intake (DMI) was recorded daily throughout
the 13 weeks period. Since the onset day of lactation,
cows were milked in their stalls twice per day at 05.00
and 16.00 h, and individual milk yield (MY) was re-
corded electronically. Milk composition like crude pro-
tein (CP), milk fat, lactose, somatic cell count, milk urea
nitrogen (MUN), and total solids (TS) were analyzed by
mid-infrared spectroscopy (MilkoScan 605; A/S Foss
Electric, Hillerød, Denmark) at the DHI Central Milk
Testing Laboratory in Edmonton, Alberta. Milk compos-
ition was analyzed at +2, +3, +5, and +7 weeks post-
partum.
Monitoring of clinical health status
Overall health status (HS) of cows was monitored daily,
based on clinical signs of disease by trained individuals
and on a weekly basis by a veterinary practitioner. All
periparturient diseases and veterinary treatments were
recorded for each cow throughout the entire experimen-
tal period. Based on the artificial insemination (AI) data,
supported with the information of pregnancy diagnosis,
the expected date of parturition was fixed by adding
280 days from the day of AI. All cows were monitored
daily starting at -8 weeks prior to the expected date of
calving and continuing up to +8 weeks postpartum. The
various external symptoms observed were gait, general
appearance, appetite, alertness, rectal temperature, ease
of calving, body condition score, body temperature, vagi-
nal discharges (color and consistency), udder edema,
flakes in the milk, and pain in the legs.
In this study, SCM was diagnosed according to the farm
standard operating procedures. A subclinical mastitis case
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was diagnosed if the cow had an elevated SCC but milk
appears normal. Value of SCC > 200,000 for two or more
consecutive reports were used for confirmation of SCM.
No treatment was given to the animals unless indicated by
a veterinarian.
Sample collection
Blood samples were obtained from the coccygeal vein
once per week at 07,00 before feeding from -8 weeks be-
fore parturition to +4 weeks postpartum. All blood sam-
ples were collected into 10-mL vacutainer tubes (Becton
Dickinson, Franklin Lakes, NJ, USA) and allowed to clot
and kept at 4 °C until separation of serum. Clotted blood
was centrifuged at 2090 × g at 4 °C for 20 min (Rotanta
460 R centrifuge, Hettich Zentrifugan, Tuttlingen,
Germany). The separated serum was aspirated from the
supernatant gradually by transfer pipets (Fisher Scien-
tific, Toronto, ON, Canada) without disturbing the sedi-
ment. The separated serum was transferred to a sterile
10-mL plastic test tube (Fisher Scientific, Toronto, ON,
Canada). All serum samples were stored at -80 °C until
analysis to avoid loss of bioactivity and prevent contam-
ination and were thawed on ice for approximately 2 h
before use.
Cows were milked twice per day at 05.00 and 16.00 h,
and milk samples collected on d 0, 14, 21, 35, and 49
relative to parturition (day 0 means the day of calving),
were used for analysis of milk composition including CP,
milk fat, lactose, SCC, MUN, and TS.
Sample analyses
Serum cytokines: Concentration of IL-1 in the serum
was assayed by a commercially available bovine ELISA
kit (Cusabio Biotech Co. Ltd., Wuhan, China) with mAb
(monoclonal antibodies) specific for IL-1 coated on the
walls of the microplate strips provided. The procedure
involves a competitive inhibition enzyme immunoassay
between biotin-conjugated IL-1 and IL-1 with the pre-
coated antibody. All samples (50 μL) were tested in
duplicate in microtitration wells with biotin-conjugated
IL-1 according to the manufacturer’s instructions. The
plates were washed with wash buffer after the incubation
for 60 min at 37 °C, followed by addition of 50 μL of
horseradish peroxidase (HRP)-avidin. Samples were in-
cubated for 30 min at 37 °C. Then, they were washed 3
times with buffer, and 50 μL substrate A and 50 μL of
substrate B reagent were added to each well. After incu-
bation at 37 °C for 15 min, the resulting color reaction
was read at 450 nm by a microplate reader (Spectramax
190, Molecular Devices Corporation, Sunnyvale, CA,
USA) within 10 min, and the final IL-1 concentration
was calculated using a 4-parameter logistic curve fit.
The sensitivity of this assay was 250 pg/ml, and the
intra-assay CV was < 10 %.
Concentration of IL-6 in the serum was measured
with a bovine ELISA kit provided by Uscnk Life
Science Inc. (Wuhan, China) as described by the
manufacturer. The detection limit of the assay was
7.8 pg/ml and the intra-assay variation of all IL-6 as-
says was controlled by CV limits of < 10 %. The
principle of the IL-6 test involves a sandwich enzyme
immunoassay, which exhibits a yellow color change
proportional to IL-6 concentration. Samples or stan-
dards were added to the microtiter plate wells with a
biotin-conjugated antibody specific for IL-6 with all
samples in duplicate. Then, HRP-avidin was added
and incubated. After 3, 3, 5, 5-tetramethylbenzidine
(TMB) substrate and sulphuric acid solution were
added, the color change was measured spectrophoto-
metrically at a wavelength of 450 nm (Spectramax
190, Molecular Devices Corporation, Sunnyvale, CA,
USA).
Concentration of TNF in the serum was determined
by a commercially available bovine ELISA kit (Bethyl La-
boratories, Inc., Montgomery, TX, USA) using a method
described previously by Iqbal et al. [27]. Briefly, all sam-
ples were tested in duplicate and the optical density
values were read at 450 nm on a microplate spectropho-
tometer (Spectramax 190, Molecular Devices Corpor-
ation, Sunnyvale, CA, USA). The detection range of
TNF assays was between 0.078 and 5 ng/mL, and the
intra-assay CV was lower than 10 %.
Serum APP: Methods used for measurement of con-
centrations of Hp (Tridelta Development Ltd., Co.Kil-
dare, Ireland) and SAA (Tridelta Development Ltd.) in
the serum were described previously in detail by Iqbal et
al. [28]. In brief, serum samples for SAA analyses were
initially diluted 1:500. Samples for Hp were not diluted.
The minimum detection limits for Hp and SAA assays
were 2.5 mg/mL, and 18.8 ng/mL, respectively. All sam-
ples were tested in duplicate and the optical densities
were measured at 600 nm for Hp and 450 nm for SAA.
The intra-assay variations of the two APP assays was
controlled by the CV limits of no more than 10 % and
for those greater than 10 % samples were reanalyzed.
Serum metabolites: Quantitative determination of
serum lactate, BHBA, and NEFA were measured by an
enzymatic colorimetric method using commercially
available kits provided by Stanbio Laboratory (Boerne,
TX, USA) and Wako Chemicals (Richmond, VA, USA),
respectively. The detailed methods have been described
previously by Ametaj et al. [29]. Briefly, according to the
manufacturer’s instructions, the lower detection limits of
the kits were 0.06 mg/dl, 0.125 μmol/l, and 0.50 μEq/l
for lactate, BHBA, and NEFA, respectively. The principle
of the lactate assay involves reduction in the colorless
tetrazolium salt by an NADH-coupled enzymatic reac-
tion to formazan, which develops a red color change
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proportional to the lactate concentration. BHBA test in-
volves the basic principle of conversion of serum BHBA
to acetoacetate and NADH by BHBA dehydrogenase in
presence of NAD. Then, the NADH reacts with 2-p-
iodophenyl-3-p-nitrophenyl-5-phenyltetrazolium chlor-
ide (INT) in the presence of diaphorase to form a pink
colored adduct proportional to the concentration of
BHBA in the serum. The principle of NEFA kit involves
acylation of coenzyme A (CoA) by fatty acids in the
serum in presence of acyl-CoA synthetase and produc-
tion of hydrogen peroxide in presence of acyl-CoA oxi-
dase. Hydrogen peroxide, together with peroxidase,
permits the oxidative condensation of 3-methyl-N-ethyl-
N-β-hydroxy ethyl-O-aniline with 4-aminoantipyrine to
produce a purple color change, which is proportional to
the serum NEFA concentrations. All samples were tested
in duplicate and absorbance of standards and samples vs
a blank for lactate, BHBA, and NEFA were read at 492,
505, and 550 nm, respectively, in a microplate reader
(Spectramax 190, Molecular Devices Corporation, Sun-
nyvale, CA, USA). The intra-assay variation of all the
three assays was controlled by CV limits of < 10 %.
Statistical analyses
To perform a standard cross-sectional 2-group study, we
compared healthy cows group and SCM cows group at
each time point (-8, -4, disease diagnosis, and +4 weeks).
For parametric analysis of the data ANOVA was used
by MIXED procedure of SAS (SAS Institute Inc., Cary,
NC, USA, Version 9.2) according to the following
model:
Yijk ¼ μþ Si þWj þ SWð Þij þ eijk
where Yijk is the observations for dependent variables, μ
represents the population mean, Si is the fixed effect of
health status i (i = 1–2, sick cows compared with healthy
control separately), Wj is the fixed effect of measure-
ment week j (j = 1–4 or 1–13), SWij is the fixed effect of
health status by week interaction, and eijk is the residual
error.
Measurements taken at different weeks on the same
cow were considered as repeated measures in the
ANOVA. The variance–covariance structure of the re-
peated measures was modeled separately for each re-
sponse variable according to the lowest values of the fit
statistics based on the BIC (Bayesian information cri-
teria), and an appropriate structure was fitted. Degrees
of freedom were approximated by the method of
Kenward-Roger (ddfm = kr).
In order to identify early indicators of SCM, average
serum concentrations in the week of diagnosis, -8 and
-4 weeks before the expected day of parturition were
compared using t-test of SAS 9.2 between healthy
controls and cows with SCM. Data are exhibited as
least-squares means (LSM) and the respective standard
error of the mean (SEM). All statistical tests were two-
sided. Significance was declared at P < 0.05, and ten-
dency was defined at 0.05 < P < 0.10.
Multivariate analysis was performed using MetaboA-
nalyst [30]. Recommended statistical procedures for
principal component analysis (PCA) and partial least
squares discriminant analysis (PLS-DA) were followed
according to previously published protocols [30]. To
perform a standard cross-sectional 2-group study, we
compared healthy cows group and SCM cows group at
each time point (-8, -4, disease diagnosis, and +4 weeks).
In the PLS-DA model, a variable importance in the
projection (VIP) plot was used to rank the variables
based on their importance in discriminating ketosis
group from the CON group of cows. Variables with the
highest VIP values are the most powerful group discrim-
inators. Typically, VIP values > 1 are significant and VIP
values > 2 are highly significant.
Biomarker profiles and the quality of the biomarker
sets were determined using receiver-operator character-
istic (ROC) curves as calculated by MetaboAnalyst 3.0
[31]. Paired sensitivity and false-positive ratios (1-specifi-
city) at different classification decision boundaries were
calculated. A ROC curve is plotted with sensitivity
values on the Y-axis and the corresponding false-positive
rates (1-specificity) on the X-axis. ROC curves are often
summarized into a single metric known as the area
under the curve (AUC), which indicates the accuracy of
a test for correctly distinguishing one group such as
SCM cows from CON ones. If all positive samples are
ranked before negative ones, the AUC is 1.0, which indi-
cates a perfectly discriminating test. The 95 % confi-
dence interval (CI) and P values were calculated. A
rough guide for assessing the utility of a biomarker set
based on its AUC is 0.9 ~ 1.0 = excellent; 0.8 ~ 0.9 =
good; 0.7 ~ 0.8 = fair; 0.6 ~ 0.7 = poor; 0.5 ~ 0.6 = fail.
Results
Serum cytokines
Data with respects to concentrations of IL-1, IL-6, and
TNF in the serum are shown in Fig. 1. Overall data
showed that cows with SCM had greater concentrations
of TNF throughout the study (P < 0.05); with sampling
week also having an effect on the results (P < 0.0). Com-
parisons also showed greater concentrations of TNF in
cows with SCM at -4 weeks prior to parturition and at
the week of diagnosis of the disease (P < 0.05) and it
continued at +4 week after parturition (0.28 ± 0.04 vs
0.07 ± 0.04; P < 0.01). Interleukin-1 was lower in cows
with SCM at -4 weeks before parturition (P < 0.01) and
increased during the week of diagnosis of disease in
SCM cows (P < 0.05), whereas IL-6 did not show
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Fig. 1 Concentrations of (a) interleukin (IL) - 1, (b) interleukin (IL) – 6, and (c) tumor necrosis factor (TNF) in the serum of periparturient dairy
cows with (■, n = 6) or without (◇; n = 6) subclinical mastitis (SCM) (LSM ± SEM; Hs = effect of health status; Wk = effect of sampling week; Hs ×
Wk = effect of health status by sampling week interaction)
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differences between the two groups, during the time
points investigated in this study (P > 0.05).
Serum acute phase proteins
Results with regards to concentrations of Hp and SAA
in the serum are shown in Fig. 2. Overall data showed
no differences in concentrations of Hp between CON
cows and those with SCM (P > 0.05); with the sampling
week and interaction of health status by sampling week
having a significant effect (P < 0.05). Cows with SCM
had lower Hp compared to CON ones at -8 and -4 weeks
prior parturition and at +4 weeks after parturition. At
the week of diagnosis of disease, concentrations of Hp
were greater in cows with SCM (P < 0.05).
Overall cows with SCM had greater concentrations of
SAA compared to healthy cows throughout the study (P
< 0.05). Comparison of means at -8 and -4 weeks before
parturition did not show significant changes between the
Fig. 2 Concentrations of (a) haptoglobin (Hp), and (b) serum amyloid A (SAA) in the serum of periparturient dairy cows with (■, n = 6) or without
(◇; n = 6) subclinical mastitis (SCM) (LSM ± SEM; Hs = effect of health status; Wk = effect of sampling week; Hs ×Wk = effect of health status by
sampling week interaction)
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Fig. 3 Concentrations of (a) lactate, (b) non-esterified fatty acids (NEFA), and (c) β-hydroxybutyric acid (BHBA) in the serum of periparturient dairy
cows with (■, n = 6) or without (◇; n = 6) subclinical mastitis (SCM) (LSM ± SEM; Hs = effect of health status; Wk = effect of sampling week; Hs ×
Wk = effect of health status by sampling week interaction)
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two groups. However, results showed a tendency for
greater concentrations of SAA (P = 0.05) at the week of
diagnosis of disease and +4 weeks (P = 0.05).
Serum metabolites
Alterations in serum metabolites including lactate,
BHBA, and NEFA are shown in Fig. 3, whereas con-
centrations of metabolites for the prepartum period
are shown in Tables 1 and 2. Overall data demon-
strated that concentrations of lactate in cows with
SCM were greater compared to healthy animals
(3043 μmol/L vs 2242; P < 0.05). The effect of sam-
pling week was also significant (P < 0.05), indicating a
week-to-week variation in lactate concentration.
Furthermore comparison of means at -8 and -4 weeks
before parturition showed that cows with SCM had
greater concentrations of lactate compared to CON
cows (P < 0.05). No differences in lactate concentra-
tions were detected between healthy cows and those
with SCM at the diagnosis week; however at +4 weeks
lactate concentration increased in cows with SCM
(2100 ± 129 μmol/L vs 2999 ± 76 μmol/L; P < 0.01).
Moreover, no differences between the two groups of
cows were detected with respect to concentrations of
NEFA and BHBA in the serum; however, results
showed an effect of week of sampling on both those
variables (P < 0.05). A tendency for greater concentra-
tions of NEFA (P = 0.09) and BHBA (P = 0.08) in cows
with SCM, at -4 weeks prior to parturition, was ob-
served. Concentrations of lactate and BHBA also were
not different between the CON and sick cows during
the week when SCM was diagnosed.
Dry matter intake, milk production, and milk composition
Data related to DMI and milk production are shown in
Fig. 4, whereas concentrations of milk fat, protein, and
fat:protein ratio in the milk are presented in Fig. 5.
Moreover SCC, TS, and lactose in the milk are shown in
Fig. 6.
Overall cows with SCM had lower DMI intake
compared to healthy cows (P < 0.05). The sampling week
had an effect (P < 0.05), indicating a week-to-week vari-
ation in DMI. Comparison of means demonstrated that
DMI tended to be lower at -4 weeks before parturition
Table 1 Data of DMI, milk production, milk composition and metabolites, cytokines, and APP in the serum of dairy cows with (n = 6)
and without subclinical mastitis (SCM) during the periparturient period
Groupa Effect,b P-value
Item SCM CON SEM Hs Wk Hs ×Wk
DMIc (kg/d) 16.90 18.64 0.72 0.02 <0.01 0.09
Milk productiond (kg/d) 33.76 42.16 2.52 0.04 <0.01 0.37
Milk compositione (g/kg, unless otherwise stated)
Fat 3.67 3.84 0.23 0.63 0.24 0.23
Protein 2.92 2.86 0.05 0.39 0.04 0.19
Fat:protein ratio 1.27 1.37 0.10 0.51 0.24 0.23
Lactose 4.59 4.56 0.05 0.72 0.03 0.86
SCC (103 cells/mL) 628.44 29.38 124.45 <0.01 0.20 0.21
Milk urea N (mg/dL) 17.43 15.61 1.02 0.24 0.53 0.38
TS 12.21 12.21 0.20 0.98 0.40 0.44
Serum parametersf
Lactate (μmol/L) 3,043.38 2,242.94 149.29 <0.01 0.04 0.08
NEFA (mmol/L) 205.46 397.17 64.62 0.07 <0.01 0.14
BHBA (μmol/L) 520.81 596.03 73.09 0.50 <0.01 0.65
IL-1 (pg/mL) 299.19 296.62 4.72 0.71 <0.01 0.04
IL-6 (pg/mL) 19.05 26.70 6.42 0.47 0.15 0.10
TNF (ng/mL) 0.52 0.19 0.04 <0.01 <0.01 <0.01
Haptoglobin (mg/mL) 0.14 0.15 0.01 0.37 <0.01 <0.01
SAA (ug/mL) 23,915 8,514.32 2,517.79 <0.01 0.16 0.40
aCON = cows without subclinical mastitis (health control); SCM = cows with subclinical mastitis
bEffect of health status (Hs), sampling week (Wk), and health status by sampling week interaction (Hs ×Wk)
cDry matter intake was calculated from week -8 to +8 relative to parturition
dMilk production was calculated from week +1 to +8 relative to parturition
eMilk compositions were determined on week +2, +3, +5, +7 relative to parturition
fSerum parameters were calculated from week -8, -4, disease, and +4 relative to parturition
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Table 2 Data of DMI, milk production, milk composition, and various serum variables related to carbohydrate metabolism as well as to proinflammatory cytokines and acute
phase proteins at the diagnosis week, and prior to the diagnosis of subclinical mastitis (SCM) at -8 and -4 weeks prior to expected day of parturition
-8 weeks before parturation 4 weeks before parturation SCM diagnosis weeka 4 weeks after parturition
Item CON SCM P-value CON SCM P-value CON SCM P-value CON P-value SCM P-value
DMI (kg/d) 16.27 ± 1.04 14.94 ± 1.04 0.42 15.93 ± 0.10 12.98 ± 0.75 0.05 20.34 ± 0.56 16.23 ± 0.44 <0.01 21.16 ± 0.68 22.46 ± 1.79 0.23
Milk production (kg/d) 43.01 ± 1.62 28.23 ± 3.95 <0.01 42.04 ± 2.21 35.36 ± 3.96 0.17
Milk composition
(g/kg, unless otherwise stated)
Fat 5.08 ± 0.45 3.32 ± 0.41 0.02
Protein 3.00 ± 0.10 2.97 ± 0.09 0.86
Fat : Protein ratio 1.69 ± 0.12 1.11 ± 0.12 <0.01
Lactose 4.54 ± 0.05 4.53 ± 0.06 0.92
SCC (103 cells/mL) 28.33 ± 5.63 1,867 ± 699 0.02
Milk urea N (mg/dL) 15.39 ± 0.76 18.70 ± 1.11 0.03
TS 12.21 ± 0.31 12.19 ± 0.26 0.95
Serum parameters
Lactate (μmol/L) 2,455 ± 349 3,478 ± 153 0.03 2,162 ± 184 3,467 ± 546 0.04 2,228 ± 320 2,215 ± 203 0.98 2,100 ± 129 2,999 ± 76 <0.01
NEFA (mmol/L) 141 ± 32.77 179 ± 42.91 0.51 194 ± 47.17 92.97 ± 10.42 0.09 756 ± 232 303 ± 55 0.11 500.43 ± 151.71 243.89 ± 39.28 0.16
BHBA (μmol/L) 352 ± 37.71 336 ± 42.62 0.78 312 ± 18.50 354 ± 3.32 0.08 827 ± 151 598 ± 176 0.35 896.73 ± 188.3 777.8 ± 91.43 0.58
IL-1 (pg/mL) 316.79 ± 6.04 308 ± 13.76 0.55 321 ± 1.59 306. ± 1.46 <0.01 277. ± 5.42 297 ± 4.50 0.02 270.57 ± 2.87 283.02 ± 7.22 0.14
IL-6 (pg/mL) 19.23 ± 5.67 13.23 ± 3.15 0.42 48.24 ± 17.51 14.75 ± 6.13 0.24 23.17 ± 5.18 23.43 ± 4.89 0.97 15.71 ± 3.27 21.73 ± 6.02 0.38
TNF (ng/mL) 0.34 ± 0.03 0.35 ± 0.02 0.96 0.27 ± 0.05 1.29 ± 0.05 <0.01 0.06 ± 0.03 0.23 ± 0.01 0.01 0.07 ± 0.04 0.28 ± 0.04 0.01
Haptoglobin (mg/mL) 0.19 ± 0.03 0.05 ± 0.01 <0.01 0.15 ± 0.01 0.07 ± 0.01 <0.01 0.12 ± 0.01 0.33 ± 0.02 <0.01 0.16 ± 0.01 0.10 ± 0.02 0.04
SAA (ug/mL) 8,448 ± 3,373 8,799 ± 1,464 0.96 3,461 ± 342 21,052 ± 12,162 0.39 10,401 ± 1722 33,705 ± 9,459 0.05 11,797 ± 1,853 31,419 ± 8,039 0.05














(P = 0.05) and was lower in cows with SCM during the
week of diagnosis of disease (P < 0.05).
Moreover cows with SCM showed lower milk produc-
tion throughout the postpartum period and especially
during the week of diagnosis of disease (28.23 ± 3.95 vs
43.01 ± 1.62; P < 0.01). Fat content was not different be-
tween the two groups; however, at the week of diagnosis
of SCM, those cows had significantly lower milk fat con-
tent (3.32 ± 0.41 vs 5.08 ± 0.45; P < 0.05). Moreover, fat
to protein ratio in the milk was lower in SCM cows
compared to healthy cows at the week of SCM diagnosis
(P < 0.05). In addition, SCC were greater in cows with
SCM compared to healthy animals throughout the post-
partal period and during the week of SCM diagnosis
(1867 ± 698.95 vs 28.33 ± 5.63; P < 0.05). Cows with SCM
also had greater MUN at the week of diagnosis of SCM,
whereas lactose and TS did not show differences
between the two groups (Table 2).
Multivariate analysis
Comparisons between the healthy cows and SM ones at
-8 weeks prepartum, PCA (Principal Componenet Ana-
lysis) analysis showed that the first 2 PC (principal com-
ponents) covered 55.9 % of the observed variance in the
Fig. 4 a DMI (Dry Matter intake), and (b) milk production of periparturient dairy cows with (■, n = 6) or without (◇; n = 6) subclinical mastitis
(SCM) (LSM ± SEM; Hs = effect of health status; Wk = effect of sampling week; Hs ×Wk = effect of health status by sampling week interaction)
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Fig. 5 Concentrations of (a) fat, (b) protein, and (c) fat:protein ratio in the milk of periparturient dairy cows with (■, n = 6) or without (◇; n = 6)
subclinical mastitis (SCM) (LSM ± SEM; Hs = effect of health status; Wk = effect of sampling week; Hs ×Wk = effect of health status by sampling
week interaction)
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Fig. 6 Concentrations of (a) somatic cell count (SCC), (b) milk urea N (MUN), (c) total solid (TS), and (d) lactose in the milk of periparturient dairy
cows with (■, n = 6) or without (◇; n = 6) subclinical mastitis (SCM) (LSM ± SEM; Hs = effect of health status; Wk = effect of sampling week; Hs ×
Wk = effect of health status by sampling week interaction
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sample set (Fig. 7a). In addition PLS-DA scores plot re-
vealed that it is possible to discriminate between healthy
cows and those with SCM starting at -8 weeks prior to
the expected day of parturition (Fig. 7b). When healthy
cows and SCM ones were compared at -4 week prior to
parturition (Fig. 8a), PCA analysis showed that the first
2 PC covered 75.9 % of the observed variance in the
sample. PLS-DA scores plot also revealed that it is pos-
sible to discriminate between CON cows and those with
SCM starting at -4 weeks before the expected day of
parturition (Fig. 8b). Similar results were obtained for
the week of diagnosis of SCM (Fig. 9a and b). A VIP plot
in a PLS-DA model at 4 time points in which the serum
variables were ranked based on their contribution to dis-
criminating the SM cows from CON ones are shown in
Figs. 7c, 8c, 9c and 10c. The VIP plots indicated that Hp
lactate, and SAA at -8 weeks; TNF, IL-1, and SAA at
-4 weeks; Hp, TNF and SAA at the week of diagnosis of
SCM; and lactate, TNF, and Hp at +4 weeks were the
strongest discriminating variables for separating SCM
cases form CON cows. The heat map on the right side
of the 4 VIP plots indicated that these variables were en-
hanced in cows with SCM relative to CON cows.
A ROC curve plot indicating the performance of the
top 3 metabolites in predicting which cows will develop
SCM at -8 and -4 weeks using a PLS-DA model are
shown in Figs. 7d and 8d. The AUC for the curve at
-8 weeks is 0.995 (95 % CI, 1-1), which indicates that Hp
lactate, and SAA together, at -8 weeks have strong pre-
dictive abilities. The AUC for the curve at -4 weeks is 1
(95 % CI, 1-1), which suggest that at – 4 weeks the com-
bination of TNF and IL-1 have very strong predictive
abilities. These results demonstrate that biomarker
models developed at -8 and -4 weeks could be used to
predict which cows are susceptible to develop SCM after
parturition. The week of diagnosis of disease was at +2
to +3 weeks postpartum. The ROC curve developed
based on three metabolites Hp, TNF and SAA at the
week of diagnosis of SCM indicates that this three-
metabolite set were a highly significant biomarker for
diagnosis of SCM: AUC, 1 (95 % CI, 1-1, Fig. 9d). More-
over, multivariate models (ROC curves) combining 3
Fig. 7 a Principal component analysis (PCA) and (b) Partial least squares-discriminant analysis (PLS-DA) of 6 control (red triangles), and 6 subclinical
mastitis cows (green + sign), at -8 weeks before parturition showing 2 separated clusters for 2 groups. c Variables ranked by variable importance in
projection (VIP), and (d) Receiver-operator characteristic (ROC) curve of 6 CON and 6 SCM cows at -8 weeks before parturition for the top 3
serum variables
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discriminating variables (i.e., lactate, TNF, and Hp) at
+4 weeks produced an area under the receiver-operating
curve of 0.965 (95 % CI: 0.5–1, Fig. 10d).
Discussion
We hypothesized that alterations of innate immunity re-
actants as well as changes in carbohydrate and lipid me-
tabolism could precede development of SCM in
transition dairy cows. Indeed, results revealed multiple
alterations in innate immunity and metabolic variables
several weeks prior to the expected day of parturition
and prior to diagnosis of SCM. Cows affected by SCM
had greater concentration of TNF, SAA, and lactate,
lower DMI and milk production, and an increase in milk
SCC.
Concentrations of TNF were greater in the serum of
cows with SCM at -4 weeks before the expected day of
parturition and at the week of SCM diagnosis, compared
to their healthy counterparts. Tumor necrosis factor has
been related previously to inflammation of the udder
[32]. In LPS-induced mastitis models, TNF is detected in
the plasma and milk of early lactating cows [33, 34]. In
addition, during natural coliform mastitis or experimen-
tal E. coli infection TNF is significantly increased in both
milk and serum [34, 35]. However, it should be noted
that in serum, concentration of TNF is only extensively
elevated in severe clinical cases of coliform mastitis [34,
36]. Results of the study also showed that serum IL-1
was greater in SCM cows at the week of SCM diagnosis
but lower at -4 weeks prior to parturition. Greater con-
centrations of IL-1 and TNF in the serum, at the week
of SCM diagnosis, suggest presence of inflammation in
the udder. TNF and IL-1 are produced by activated mac-
rophages and neutrophils present in the infected mam-
mary gland [37]. Concentrations of IL-1 and TNF in the
milk are related to recruitment of neutrophils to the
mammary gland [33]. Both IL-1 and TNF serve as
activators of APP production in liver hepatocytes [33,
38]. To our best knowledge this is the first study to re-
port that SCM was preceded by elevation of TNF
Fig. 8 a PCA and (b) PLS-DA of 6 controls (red triangles), and 6 subclinical mastitis cows (green + sign) at -4 week before parturition showing 2
separated clusters for 2 groups. c VIP, and (d) ROC curve of 6 CON and 6 SCM cows at -4 weeks before parturition for the top 3 serum variables
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concentrations starting at -4 weeks before the expected
day of parturition, suggesting that TNF might be used as
early screening biomarker of disease state in transition
dairy cows. It has been previously reported that E. coli
or LPS-induced mastitis induced a quick and strong
transcriptome response in liver, causing up- regulation
of acute phase proteins genes [39, 40].
Circulatory pro-inflammatory cytokines are known to
trigger production of APP from liver hepatic cells, in-
creasing concentrations of peripheral plasma APP
around parturition [16, 41]. Indeed TNF concentrations
and serum SAA were greater in SCM cows. However, re-
sults of this study showed lower concentrations of Hp in
SCM cows versus healthy cows at -8 and -4 weeks pre-
partum. Since cows affected by SCM were in an inflam-
matory state during the dry off, as indicated by greater
concentrations of TNF and SAA, it is possible that lower
Hp in their blood during -8 and -4 weeks prior to
parturition might suggest movement of Hp into the
udder to help with immune responses. Haptoglobin ac-
tively participates in all the inflammatory processes from
neutrophil recruitment and free radical quenching, to
tissue repair and regeneration [42]. On another note,
lowering of Hp protein in the blood can make cows sus-
ceptible to infection and inflammatory diseases during
the transition period. It should be pointed out that
plasma concentrations of Hp increased in SCM cows
during the week of diagnosis of SCM. These results are
in line with those of Humblet et al. [43] and Rezamand
et al. [44]. Haptoglobin scavenges hemoglobin and pre-
vents utilization of iron by bacteria translocated into the
blood systemic circulation [45], and plasma Hp is con-
sidered an indicator of inflammation and infection [43].
In our study concentrations of SAA in the serum were
greater in cows with SCM throughout the study. Acute
phase proteins have been reported to increase in serum
Fig. 9 a PCA and (b) PLS-DA of 6 controls (red triangles), and 6 subclinical mastitis cows (green + sign), at disease week showing 2 separated
clusters for 2 groups. c VIP, and (d) ROC curve of 6 CON and 6 SCM cows at disease week for the top 3 serum variables
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and milk of cows with clinical and subclinical mastitis.
Our results are in agreement with other authors that
have reported about SAA and mastitis [23, 46, 47].
Serum amyloid A binds to high-density lipoproteins and
participates in expedited clearance of translocated endo-
toxin through the liver [48]. In addition, SAA is present
in secretory epithelial cells of the mammary gland at sig-
nificantly greater levels in infected udders and may play
a significant role in early response to invasion of mam-
mary tissues by pathogenic bacteria and might protect
the teat potential colonization of that area by bacteria
during milking or suckling [16, 23]. Based on greater
TNF and SAA during the dry off period it is speculated
that the infection of the udder might have started imme-
diately after drying off and cows of SCM group have
been in a state of endotoxemia during the entire dry off
period and immediately after calving.
One of the most interesting finding of this study was
that cows with SCM had greater concentrations of lac-
tate in the serum starting at -8 weeks before parturition.
Several authors have described elevation of lactate con-
centrations in the milk during presence of clinical mas-
titis, suggesting that lactate could be a good indicator of
udder health [12, 13]. Lactate also is an indicator of
death in humans and ruminants [49, 50]. It should be
kept in mind that SM is diagnosed based on the number
of somatic cells in the milk postpartum. Previously, it
has been reported that high levels of milk lactate are
closely related to SCC [13], making lactate a potential
indicator of clinical and subclinical mastitis. High lactate
also happens during sepsis or endotoxemia. These data
support our assumption SCM cows were in a state of
endotoxemia because during these conditions there is
enhanced peripheral glucose utilization and increased
Fig. 10 a PCA and (b) PLS-DA of 6 controls (red triangles), and 6 subclinical mastitis (green + sign), at 4 week after parturition showing 2 sepa-
rated clusters for 2 groups. c VIP, and (d) ROC curve of 6 CON and 6 SCM cows at +4 weeks after parturition for the top 3 serum variables
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gluconeogenesis [51]. For example Lang et al. [52]
showed that the major gluconeogenic precursor, lactate,
was markedly elevated following endotoxin administra-
tion. Lactate is also produced from monocytes/macro-
phages [53]. Moreover proinflammatory cytokines like
TNF and IL-1 have been shown to increase glycolysis
but lower oxidation of glucose within the tricarboxylic
cycle, contributing to elevation of lactate [54]. To our
best knowledge, this is the first study to relate concen-
trations of plasma lactate with SCM starting at -8 weeks
prior to the expected day of parturition. Intriguingly lac-
tate inhibits affect T cell motility to the inflammation
site and its effector functions [55]. In addition lactate
suppresses T cell cytotoxic activity [56], alter antigen-
presenting ability of dendritic cells [57], and interfere
with NK cell activity [58].
Dry matter intake was lower starting at -4 weeks be-
fore parturition and was lower in cows affected by SCM.
One of the most important physiological changes occur-
ring during dry off period is a decrease in DMI [59] and
lower feed intake is known to be associated with a drop
in body weight. Gonzalez et al. [60] reported that
changes in eating behavior are potential indicators for
monitoring health disorders of dairy cows. In addition,
Huzzey et al. [61] showed that prepartum DMI is able to
identify cows at risk for metritis. Dry matter intake, and
subsequently nutrient intake, is lowered before calving
and remains low for a few days after calving. This period
often represents a time when the immune system of the
cow is severely suppressed, making cows particularly
vulnerable to infectious diseases such as mastitis [62].
Endotoxemia lowers DMI [63, 64], therefore it is hy-
pothesized that cows (not yet diseased) in our experi-
ment might have been experiencing endotoxemia at
-4 weeks before calving. The reason for the decrease in
DMI in SCM cows might be the increase in TNF con-
centration. Proinflammatory cytokines are known to
affect feed intake and in this study TNF was greater in
dairy cows prior to diagnosis of SCM [65]. These results
suggest that DMI might be an early indicator of SCM in
dairy cows.
Subclinical mastitis is associated with lowering of milk
production and significant financial losses to the dairy in-
dustry [66]. In our study cows with SCM had lower milk
production throughout the postpartal experimental
period. The reason why cows with SCM had lower milk
production can be related to increased concentrations of
TNF in the serum. It has been reported that infection by
Gram-negative bacteria and their cell wall component,
lipopolysaccharide (LPS), trigger inhibition of prolactin
production, indirectly through TNF, in the pituitary gland
Theas et al. [67]. Prolactin is a known hormone related to
stimulation of milk production. This assumption is
supported by a previous investigation demonstrating a
decrease in milk yield in lactating cows after parenteral
administration of TNF Kushibiki et al. [68].
During SCM no visible changes occur in the ap-
pearance of the udder; however, milk production de-
creases, SCC increases, and milk composition is
altered [3]. Indeed in the present study SCM was as-
sociated with a decrease in milk production and alter-
ations in milk composition. Cows with SCM had
greater SCC and MUN, lower milk fat and fat:protein
ratio during the week of disease diagnosis (P < 0.05).
Milk fat is often used as an indicator of rumen health
and forage intake [69, 70] and has been often used as
an indicator of subacute ruminal acidosis (SARA) in
dairy cows. Duffield et al. [71] suggested the ratio of
fat: protein as a breakpoint for ketosis in dairy cows.
In addition, lower fat:protein ratio in cows with SCM
indicates that these cows are at high risk of SARA.
The results of our study suggest that SCM cows
might have been in a state of endotoxemia. Previ-
ously, Zebeli and Ametaj [72] reported a strong cor-
relation between rumen endotoxin and milk fat
content. During endotoxemia lipids deflect to liver
instead of supporting the udder lipid metabolism
because lipoproteins that bind and carry endotoxin
diverge to the liver to excrete LPS through bile. This
might have contributed to lower fat content in the
milk. As expected cows with SCM showed greater
SCC in the milk compared with healthy cows (P <
0.05) throughout the postpartal period, which served
also for diagnosis of cows with SCM. Of note cows
going through SCM are at risk of developing clinical
mastitis [44, 73]. Reduced MUN, milk protein, and
lactose synthesis have been previously described to be
lower in cows with SCM, and may indicate a transi-
ent dietary protein deficiency [44]. In addition Obled
et al. [74] demonstrated that during inflammation and
disease states, the requirement for some amino acids
are significantly increased.
Conclusions
Overall, the results of this study indicate that cows
affected by SCM display an activated innate immunity
and altered carbohydrate metabolism weeks before of
diagnosis of the disease. More specifically, cows with
SCM had greater serum lactate, SAA, TNF, and lac-
tate prior to parturition and at diagnosis of SCM. In
addition subclinically diseased cows showed alter-
ations in milk production, milk composition, and
DMI. Furthermore multivariate analysis of the data
(PCA and PLS-DA) supports the fact that it is pos-
sible to discriminate between healthy cows and those
with SCM at -8 weeks before parturition. Results of
our study support the idea that Hp lactate, and SAA,
at -8 weeks, and TNF and IL-1 at -4 weeks might be
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used to screen cows during dry off for disease state.
Since innate immunity is a general non-specific im-
mune response the identified variables might be used
to indicate a non-health status more than a specific
disease. More research and a greater number of ani-
mals are warranted to understand the pathogenesis of
SCM and to validate these results in the future.
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